About Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gruppo Italiano Malattie EMatologiche dell'Adulto
23
Fondazione Italiana Linfomi ONLUS
4
Hoffmann-La Roche
4
Janssen Research & Development, LLC
2
Associazione Italiana Ematologia Oncologia Pediatrica
1
Fondazione Amelia Scorza Onlus
1
Incyte Corporation
1
Millennium Pharmaceuticals, Inc.
1
Clinical Trials at Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia
During the past decade, Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
2002-06-01
2004-12-01
Completed
620
FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients
2003-07-31
2012-05-31
Completed
552
"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients
2007-11-01
2020-01-28
Completed
102
Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase
2007-06-23
2018-04-30
Completed
74
Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy
2008-02-01
2016-01-01
Completed
42
A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia.
2008-11-03
2013-01-14
Completed
97
Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia
2008-12-01
2013-10-23
Completed
60
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 23 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 4 trials
sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Associazione Italiana Ematologia Oncologia Pediatrica"
with 2 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia"
#1 collaborator was "Biogen" with 1 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator, "Fondazione Adecco per le Pari Opportunità" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia
According to Clinical.Site data, the most researched conditions in "Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia" are
"Chronic Lymphocytic Leukemia" (6 trials), "Leukemia" (4 trials), "Acute Lymphoblastic Leukemia" (3 trials), "Multiple Myeloma" (3 trials) and "Myelodysplastic Syndrome" (3 trials). Many other conditions were trialed in "Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia" in a lesser frequency.
Clinical Trials Intervention Types at Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia
Most popular intervention types in "Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia" are "Drug" (27 trials), "Other" (4 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (3 trials), "Bortezomib" (2 trials), "Eltrombopag" (2 trials), "Ibrutinib" (2 trials) and "Lenalidomide" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia
The vast majority of trials in "Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia" are
36 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia
Currently, there are NaN active trials in "Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 29 completed trials in Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia, 3 "Phase 1"
clinical trials were conducted, 18 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".